APA (7th ed.) Citation

Abdulakutty, J., Abhyankar, A., Seth, S., Sharma, K., Aggarwal, R. K., Bhalani, N., . . . Gawde, A. (2026). Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management. Cardiology & Therapy, 15(1), 83. https://doi.org/10.1007/s40119-025-00442-4

Chicago Style (17th ed.) Citation

Abdulakutty, Jabir, et al. "Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management." Cardiology & Therapy 15, no. 1 (2026): 83. https://doi.org/10.1007/s40119-025-00442-4.

MLA (9th ed.) Citation

Abdulakutty, Jabir, et al. "Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management." Cardiology & Therapy, vol. 15, no. 1, 2026, p. 83, https://doi.org/10.1007/s40119-025-00442-4.